Showing results (1491-1500 of 1,861) with videos related to
Sort By:
Pageof 187
Investigative Ophthalmology & Visual Science|October 30, 2015
Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein TherapeuticsLeslie J Dickmann, Victor Yip, Cuiwen Li, et al.Acta Diabetologica|August 25, 2022
Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort studyLaura Boswell, Tonet Serés-Noriega, Alex Mesa, et al.Topics in Spinal Cord Injury Rehabilitation|December 2, 2022
Effectiveness of Abdominal Functional Electrical Stimulation for Improving Bowel Function in People With a Spinal Cord Injury: A Study Protocol for a Double-Blinded Randomized Placebo-Controlled Clinical TrialGabrielle M Allen, Anne E Palermo, Keith M D McNaughton, et al.Diabetes/Metabolism Research and Reviews|April 3, 2020
Steno type 1 risk engine and preclinical atherosclerosis in Mediterranean individuals with type 1 diabetesC Viñals, I Conget, A Pané, et al.European Journal of Immunology|June 1, 1991
Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infectionM Clerici, C O Tacket, C S Via, et al.Molecular Systems Biology|January 11, 2017
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated stateMohammad Fallahi-Sichani, Verena Becker, Benjamin Izar, et al.Spinal Cord|November 2, 2024
The effect of abdominal functional electrical stimulation on blood pressure in people with high level spinal cord injuryTeodora Bojanic, Euan J McCaughey, Harrison T Finn, et al.Journal of Clinical Medicine|January 8, 2025
Project Initiate: A Clinical Feasibility Trial of Equitable Access to Early Neurodevelopmental TherapyJessica Trenkle, Alison Liddle, Lynn Boswell, et al.BMC Public Health|December 1, 2023
Understanding gender differences of people with HIV newly diagnosed or returning to care with advanced HIV disease in Malawi: a qualitative studyLeila Katirayi, Thulani Maphosa, Lloyd Chilikutali, et al.Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.Pageof 187